Guardian Pharmacy Services, Inc. (GRDN) is a publicly traded Healthcare sector company. As of May 21, 2026, GRDN trades at $37.51 with a market cap of $2.27B and a P/E ratio of 0.00. GRDN moved +3.53% today. Year to date, GRDN is +20.69%; over the trailing twelve months it is +42.00%. Its 52-week range spans $15.52 to $41.36. Analyst consensus is strong buy with an average price target of $43.00. Rallies surfaces GRDN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes GRDN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $37.51 |
| Market Cap | $2.27B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.36 |
| 52-Week Low | $15.52 |
| Volume | 307 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.46B |
| Net Income | $53.23M |
| Gross Margin | 20.93% |
4 analysts cover GRDN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.00.